APA (7th ed.) Citation

Janjigian, Y. Y., Bendell, J., Calvo, E., Kim, J. W., Ascierto, P. A., Sharma, P., . . . Le, D. T. (2018). CheckMate-032 study: Efficacy and safety of nivolumab and nivolumab plus ipilimumab in patients with metastatic esophagogastric cancer. Journal of clinical oncology, 36(28), . https://doi.org/10.1200/JCO.2017.76.6212

Chicago Style (17th ed.) Citation

Janjigian, Yelena Y., et al. "CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients with Metastatic Esophagogastric Cancer." Journal of Clinical Oncology 36, no. 28 (2018). https://doi.org/10.1200/JCO.2017.76.6212.

MLA (9th ed.) Citation

Janjigian, Yelena Y., et al. "CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients with Metastatic Esophagogastric Cancer." Journal of Clinical Oncology, vol. 36, no. 28, 2018, https://doi.org/10.1200/JCO.2017.76.6212.